» Articles » PMID: 31059591

A Novel Mutation in Slc2a4 As a Mouse Model of Fatigue

Overview
Date 2019 May 7
PMID 31059591
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic fatigue is a debilitating disorder with widespread consequences, but effective treatment strategies are lacking. Novel genetic mouse models of fatigue may prove invaluable for studying its underlying physiological mechanisms and for testing treatments and interventions. In a screen of voluntary wheel-running behavior in N-ethyl-N-nitrosourea mutagenized C57BL/6J mice, we discovered two lines with low body weights and aberrant wheel-running patterns suggestive of a fatigue phenotype. Affected progeny from these lines had lower daily activity levels and exhibited low amplitude circadian rhythm alterations. Their aberrant behavior was characterized by frequent interruptions and periods of inactivity throughout the dark phase of the light-dark cycle and increased levels of activity during the rest or light phase. Expression of the behavioral phenotypes in offspring of strategic crosses was consistent with a recessive inheritance pattern. Mapping of phenotypic abnormalities showed linkage with a single locus on chromosome 1, and whole exome sequencing identified a single point mutation in the Slc2a4 gene encoding the GLUT4 insulin-responsive glucose transporter. The single nucleotide change (A-T, which we named "twiggy") was in the distal end of exon 10 and resulted in a premature stop (Y440*). Additional metabolic phenotyping confirmed that these mice recapitulate phenotypes found in GLUT4 knockout mice. However, to the best of our knowledge, this is the first time a mutation in this gene has been shown to result in extensive changes in general behavioral patterns. These findings suggest that GLUT4 may be involved in circadian behavioral abnormalities and could provide insights into fatigue in humans.

Citing Articles

Genetic variants associated with chronic fatigue syndrome predict population-level fatigue severity and actigraphic measurements.

Liu P, Raizen D, Skarke C, Brooks T, Anafi R Sleep. 2024; 48(2).

PMID: 39442002 PMC: 11807886. DOI: 10.1093/sleep/zsae243.

References
1.
Harno E, Cottrell E, White A . Metabolic pitfalls of CNS Cre-based technology. Cell Metab. 2013; 18(1):21-8. DOI: 10.1016/j.cmet.2013.05.019. View

2.
Sprangers M, Thong M, Bartels M, Barsevick A, Ordonana J, Shi Q . Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Qual Life Res. 2014; 23(7):1997-2013. PMC: 4199387. DOI: 10.1007/s11136-014-0656-1. View

3.
Fam B, Rose L, Sgambellone R, Ruan Z, Proietto J, Andrikopoulos S . Normal muscle glucose uptake in mice deficient in muscle GLUT4. J Endocrinol. 2012; 214(3):313-27. DOI: 10.1530/JOE-12-0032. View

4.
Narita M, Nishigami N, Narita N, Yamaguti K, Okado N, Watanabe Y . Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun. 2003; 311(2):264-6. DOI: 10.1016/j.bbrc.2003.09.207. View

5.
Choeiri C, Staines W, Messier C . Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience. 2002; 111(1):19-34. DOI: 10.1016/s0306-4522(01)00619-4. View